Rinclave 625
Rinclave 625
Rinclave-625 Tablets are a combination antibiotic formulation containing Amoxycillin and Clavulanate Acid, designed to provide broad-spectrum antibacterial coverage against resistant bacterial infections. This combination is widely used for respiratory, urinary, skin, and ENT infections.
Key Ingredients & Benefits
Amoxycillin (500 mg): Broad-spectrum penicillin antibiotic effective against gram-positive and gram-negative bacteria
Clavulanate Acid (125 mg): Beta-lactamase inhibitor that enhances the effectiveness of Amoxycillin against resistant bacterial strains
Mechanism of Action
This formulation works by:
- Inhibiting bacterial cell wall synthesis
- Blocking beta-lactamase enzymes responsible for antibiotic resistance
- Providing enhanced antibacterial coverage against resistant pathogens
- Helping achieve faster infection control
Indications
- Respiratory tract infections
- Urinary tract infections
- Ear, nose, and throat infections
- Skin and soft tissue infections
- Dental and bacterial infections
Key Benefits
- Broad-spectrum antibacterial action
- Effective against resistant bacterial strains
- Provides reliable infection management
- Trusted antibiotic combination therapy
- Suitable for various bacterial infections
Directions for Use
- Take as directed by physician
- Usually taken after meals with water
- Complete the full prescribed antibiotic course
Safety Information
Generally well tolerated
Possible side effects:
- Nausea
- Diarrhea
- Abdominal discomfort
- Allergic reactions (rare)
Precautions
Consult doctor if:
- Allergic to penicillin antibiotics
- Pregnant or breastfeeding
- Having liver or kidney disorders
Storage
Store in a cool, dry place
Protect from moisture and direct sunlight
Quality Assurance
Manufactured in GMP-certified facilities
Quality tested for safety, purity, and efficacy
Additional information
| Packing | |
|---|---|
| Pack Type |
